Altria Group, Inc. logo

Altria Group, Inc. (MO)

Market Open
24 Jul, 13:55
NYSE NYSE
$
72. 69
+0.61
+0.8463%
$
120.37B Market Cap
8.52 P/E Ratio
4.24% Div Yield
297,435 Volume
4.95 Eps
$ 72.08
Previous Close
Add Transaction
Day Range
72.08 72.75
Year Range
54.7 75.28
Want to track MO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Juul E-Cigarette Ban Reversed Pending FDA Review

Juul E-Cigarette Ban Reversed Pending FDA Review

The jury is still out on the safety of the chemical additives that go into the popular devices.

Cnet | 2 years ago
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Altria Stock

Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Altria Stock

Altria currently offers an 8.4% dividend yield. The company is struggling against significant headwinds for cigarette sales.

Fool | 2 years ago
Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Walgreens Boots Alliance cut its dividend earlier this year, but even with the new payout, its yield remains high. Altria faces a challenging road ahead as tobacco use declines, but the company's dividend still looks safe right now.

Fool | 2 years ago
Juul e-cigarettes back under FDA review after marketing ban lifted

Juul e-cigarettes back under FDA review after marketing ban lifted

The US Food and Drug Administration (FDA) is rescinding an order that blocked the sale of Juul's products, including its e-cigarettes. The FDA in June 2022 banned all of Juul's products in the US, including the Juul device and four types of flavored Juul pods, on the basis that there was not sufficient evidence the marketing of the products would be appropriate for the protection of public health.

Proactiveinvestors | 2 years ago
Juul e-cigarettes' FDA ban lifted

Juul e-cigarettes' FDA ban lifted

The U.S. Food and Drug Administration said Thursday that it has rescinded its 2022 orders blocking the marketing of Juul Labs Inc.'s e-cigarette products in the U.S.

Marketwatch | 2 years ago
FDA Rescinds Ban On Juul E-Cigarettes

FDA Rescinds Ban On Juul E-Cigarettes

The Food and Drug Administration rescinded its ban on Juul Lab's e-cigarette products Thursday—placing them back under scientific review—nearly two years after ordering a ban that was halted pending the company's appeal.

Forbes | 2 years ago
US FDA rescinds market denial order for Juul products

US FDA rescinds market denial order for Juul products

The U.S. Food and Drug Administration (FDA) said on Thursday it was rescinding a June 2022 order that briefly blocked sale of Juul's products, including its device for e-cigarettes.

Reuters | 2 years ago
Why Altria Stock is Still a Good Dividend Play

Why Altria Stock is Still a Good Dividend Play

Altria NYSE: MO is among the leading sin stocks but is still a good dividend play today. Up more than 17.5% in the last few weeks, the purveyor of tobacco products is on track to reclaim the high end of a long-term trading range and possibly set new highs.

Marketbeat | 2 years ago
Where Will Altria Stock Be in 5 Years?

Where Will Altria Stock Be in 5 Years?

Altria's main business is selling cigarettes in the United States. Cigarette volumes in the U.S. have been declining for years.

Fool | 2 years ago
Altria: The Dividend King Is Alive, I'm Still Adding To My Position

Altria: The Dividend King Is Alive, I'm Still Adding To My Position

Altria Group, Inc. has been one of my favorite dividend picks, and since the publication of my first bull thesis back in February this year, the stock has outperformed the market. This could signal that potentially the Company has now landed in a territory of overvaluation. In this article, I dissect the recent earnings report and share the reasons why I am consistently reinvesting the dividends and adding to my position in Altria.

Seekingalpha | 2 years ago
With Over 10% Gains This Year Is Altria Stock A Better Pick Than Freeport?

With Over 10% Gains This Year Is Altria Stock A Better Pick Than Freeport?

We believe that Altria stock (NYSE: MO) is a better pick over Freeport-McMoRan stock (NYSE: FCX), given its better prospects. Although these companies are from different sectors, we compare them because they have a similar market capitalization of $75-$80 billion and a similar revenue base of $20-23 billion.

Forbes | 2 years ago
1 Stock Yielding 8.6% vs. 1 Stock Yielding 5.2%: Which Is Better for Passive Income Investors?

1 Stock Yielding 8.6% vs. 1 Stock Yielding 5.2%: Which Is Better for Passive Income Investors?

At its current share price, Altria Group's dividend yields 8.6%. Philip Morris International's dividend yields 5.2%.

Fool | 2 years ago
Loading...
Load More